Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03MYX
|
||||
| Former ID |
DIB007762
|
||||
| Drug Name |
AM0010
|
||||
| Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [524564] | ||
| Company |
Armo biosciences
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-10 | Target Info | Modulator | [550272] | |
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| FoxO signaling pathway | |||||
| Jak-STAT signaling pathway | |||||
| T cell receptor signaling pathway | |||||
| Intestinal immune network for IgA production | |||||
| Pertussis | |||||
| Leishmaniasis | |||||
| Chagas disease (American trypanosomiasis) | |||||
| African trypanosomiasis | |||||
| Malaria | |||||
| Toxoplasmosis | |||||
| Amoebiasis | |||||
| Staphylococcus aureus infection | |||||
| Tuberculosis | |||||
| Epstein-Barr virus infection | |||||
| Asthma | |||||
| Autoimmune thyroid disease | |||||
| Inflammatory bowel disease (IBD) | |||||
| Systemic lupus erythematosus | |||||
| Allograft rejection | |||||
| PANTHER Pathway | Interleukin signaling pathway | ||||
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| IL4-mediated signaling events | |||||
| AP-1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.